+353-1-416-8900REST OF WORLD
1-800-526-8630U.S. (TOLL FREE)

GeoVax Labs, Inc. (GOVX) - Financial and Strategic SWOT Analysis Review

  • ID: 1292024
  • SWOT Analysis
  • May 2016
  • 46 pages
  • GlobalData
1 of 5

FEATURED COMPANIES

  • GlaxoSmithKline AG
  • Merck & Co., Inc.
  • Novartis AG
  • Sanofi-Aventis AB
  • MORE
GeoVax Labs, Inc. (GOVX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

GeoVax Labs, Inc. (GeoVax) is a biotechnology company, which develops human vaccines for diseases caused by HIV and other infectious agents using MVA-VLP vaccine platform. The company’s vaccine development programs focuses on human immunodeficiency virus (HIV), Zika virus and hemorrhagic fever viruses (Ebola, Marburg, Lassa fever) and for cancer immunotherapy. The company developed its proprietary vaccine technology in collaboration with the U.S. National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and Emory University. Its clinical trials have been funded by the National Institute of Allergy and Infectious Disease (NIAID). The company's advanced vaccines under development act against the clade B subtype of the HIV virus and clade C subtype. GeoVax is headquartered in Smyrna, Georgia, the US.

GeoVax Labs, Inc. Key Recent Developments

Mar 16, 2016: GeoVax Reports 2015 Year-End Financial Results And Provides Corporate Update
Feb 03, 2016: GeoVax to Develop Vaccine Against Zika Virus
Nov 12, 2015: GeoVax Reports 2015 Third Quarter Financial Results
Aug 04, 2015: GeoVax Reports 2015 Second Quarter Financial Results and Provides Corporate Update
May 13, 2015: GeoVax Reports 2015 First Quarter Financial Results and Provides Corporate Update

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

Loading
LOADING...

3 of 5

FEATURED COMPANIES

  • GlaxoSmithKline AG
  • Merck & Co., Inc.
  • Novartis AG
  • Sanofi-Aventis AB
  • MORE
List of Tables

List of Figures

Section 1 - About the Company

GeoVax Labs, Inc. - Key Facts

GeoVax Labs, Inc. - Key Employees

GeoVax Labs, Inc. - Key Employee Biographies

GeoVax Labs, Inc. - Major Products and Services

GeoVax Labs, Inc. - History

GeoVax Labs, Inc. - Company Statement

GeoVax Labs, Inc. - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

GeoVax Labs, Inc. - Business Description

GeoVax Labs, Inc. - Corporate Strategy

GeoVax Labs, Inc. - SWOT Analysis

SWOT Analysis - Overview

GeoVax Labs, Inc. - Strengths

Strength - Sturdy R&D Activities

Strength - Intellectual Property

Strength - HIV Vaccine Technology

GeoVax Labs, Inc. - Weaknesses

Weakness - Operating Loss Carryforward

GeoVax Labs, Inc. - Opportunities

Opportunity - Emerging Markets

Opportunity - Strategic Initiatives

Opportunity - Market Potential: HIV

GeoVax Labs, Inc. - Threats

Threat - Uncertain R&D Outcomes

Threat - Stringent Regulations

Threat - Competitive Environment

GeoVax Labs, Inc. - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

GeoVax Labs, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016

GeoVax Labs, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016

GeoVax Labs, Inc., Recent Deals Summary

Section 5 – Company’s Recent Developments

Mar 16, 2016: GeoVax Reports 2015 Year-End Financial Results And Provides Corporate Update

Feb 03, 2016: GeoVax to Develop Vaccine Against Zika Virus

Nov 12, 2015: GeoVax Reports 2015 Third Quarter Financial Results

Aug 04, 2015: GeoVax Reports 2015 Second Quarter Financial Results and Provides Corporate Update

May 13, 2015: GeoVax Reports 2015 First Quarter Financial Results and Provides Corporate Update

Mar 23, 2015: GeoVax Appoints Industry Veteran to Its Board of Directors

Mar 20, 2015: GeoVax Reports 2014 Year-End Financial Results

Section 6 – Appendix

Methodology

Ratio Definitions

About us

Contact Us

Disclaimer

List of Tables

GeoVax Labs, Inc., Key Facts

GeoVax Labs, Inc., Key Employees

GeoVax Labs, Inc., Key Employee Biographies

GeoVax Labs, Inc., Major Products and Services

GeoVax Labs, Inc., History

GeoVax Labs, Inc., Subsidiaries

GeoVax Labs, Inc., Key Competitors

GeoVax Labs, Inc., Ratios based on current share price

GeoVax Labs, Inc., Annual Ratios

GeoVax Labs, Inc., Interim Ratios

GeoVax Labs, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016

GeoVax Labs, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016

GeoVax Labs, Inc., Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

GeoVax Labs, Inc., Performance Chart (2011 - 2015)

GeoVax Labs, Inc., Ratio Charts

GeoVax Labs, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016

GeoVax Labs, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016
Note: Product cover images may vary from those shown
4 of 5
NewLink Genetics Corporation
Novartis AG
Merck & Co., Inc.
NIH AIDS Clinical Trials Information Service
U.S. Military HIV Research Program
Sanofi-Aventis AB
GlaxoSmithKline AG
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll